Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) (C-Term) Peptide

ERBB3 Reactivity: Human Host: Synthetic BP
Catalog No. ABIN8110151
$145.08
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 2 to 4 Business Days

Quick Overview for Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) (C-Term) Peptide (ABIN8110151)

Target

ERBB3 (Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3))

Origin

Human

Source

  • 9
Synthetic

Application

Blocking Peptide (BP)
  • Protein Region

    C-Term

    Purpose

    ERBB3 Peptide - C-terminal region

    Sequence

    SASLGSTQSC PLHPVPIMPT AGTTPDEDYE YMNRQRDGGG PGGDYAAMGA
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    This is a synthetic peptide designed for use in combination with anti- ERBB3 Antibody (ARP83907_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Target

    ERBB3 (Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3))

    Background

    Background Information: This gene encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound protein has a neuregulin binding domain but not an active kinase domain. It therefore can bind this ligand but not convey the signal into the cell through protein phosphorylation. However, it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers, including prostate, bladder, and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form. Additional splice variants have also been reported, but they have not been thoroughly characterized.

    Alternative Symbols: HER3, LCCS2, ErbB-3, c-erbB3, erbB3-S, MDA-BF-1, c-erbB-3, p180-ErbB3, p45-sErbB3, p85-sErbB3

    Molecular Weight

    76 kDa

    Gene ID

    2065

    NCBI Accession

    NP_001005915

    UniProt

    P21860
You are here:
Chat with us!